Article Text

Download PDFPDF
Original research
Endovascular therapy of wake-up strokes in the modern era of stent retriever thrombectomy
  1. Maxim Mokin1,
  2. Peter Kan1,
  3. Sananthan Sivakanthan1,
  4. Erol Veznedaroglu2,
  5. Mandy J Binning2,
  6. Kenneth M Liebman2,
  7. Pinakin R Jethwa2,
  8. Raymond D Turner IV3,
  9. Aquilla S Turk3,
  10. Sabareesh K Natarajan4,
  11. Adnan H Siddiqui4,
  12. Elad I Levy4
  1. 1Department of Neurosurgery and Neurology, University of South Florida, Tampa, Florida, USA
  2. 2Capital Health, Trenton, New Jersey, USA
  3. 3Departments of Neurosurgery and Radiology, Medical University of South Carolina, Charleston, South Carolina, USA
  4. 4Department of Neurosurgery, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York, USA
  1. Correspondence to Dr M Mokin, Department of Neurosurgery and Neurology, University of South Florida Neurosurgery, 2 Tampa General Circle, 7th floor, Tampa, FL 33606, USA; maximmokin{at}


Background Endovascular treatment of wake-up strokes (WUS) has been previously described, mostly with the use of pharmacological thrombolysis or first generation thrombectomy devices.

Objective To describe outcomes of WUS treated with modern endovascular therapy since the Food and Drug Administration approval of stent retrievers, and to identify predictors of good clinical outcome in this population of stroke patients.

Methods We performed a multicenter retrospective analysis of consecutive patients with WUS who underwent thrombectomy with stent retrievers Trevo (Stryker, Kalamazoo, Michigan, USA) and Solitaire FR (Covidien, Irvine, California, USA), or primary aspiration thrombectomy. We correlated favorable clinical outcomes with demographic, clinical, and technical characteristics.

Results 52 patients were included in this study; 46 (88%) cases were treated with stent retrievers and 6 (12%) were treated with primary aspiration thrombectomy alone. Successful recanalization (Thrombolysis in Cerebral Infarction (TICI) 2b/3) was achieved in 36 (69%) patients. Favorable clinical outcome at 3 months, defined as a modified Rankin Scale score of 0–2, was achieved in 25 (48%) patients. Duration of intervention <30 min and its success, defined as TICI 2b/3 recanalization, were strong predictors of favorable clinical outcome at 90 days (p<0.001 and p<0.0001, respectively).

Conclusions Our study indicates that endovascular treatment of WUS with stent retrievers and aspiration thrombectomy is safe and effective.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.